When to seek immediate medical attention: Severe abdominal pain that doesn't resolve, possibly radiating to the back (potential pancreatitis) Persistent nausea and vomiting preventing adequate fluid intake (dehydration risk) Signs of allergic reaction: difficulty breathing, swelling of face or throat, severe rash Symptoms of thyroid tumors: lump in neck, hoarseness, difficulty swallowing (rare but serious) Severe hypoglycemia symptoms when used with insulin or sulfonylureas: confusion, seizures, loss of consciousness Changes in vision or eye pain (potential diabetic retinopathy complications, particularly with rapid improvement in blood glucose) Signs of kidney problems: decreased urination, swelling in legs or feet, unusual fatigue Symptoms of gallbladder problems: pain in right or middle upper abdomen, fever, yellowing of skin/eyes These medications carry a boxed warning regarding the risk of thyroid C-cell tumors, based on animal studies
Keywords: GLP-1 therapies, Semaglutide, Liraglutide, Tirzepatide, Pharmacotherapy, Nutrition therapy, Lifestyle intervention, Lean body mass, Obesity management, Diabetes management, Weight maintenance, Gastrointestinal side effects Graphical abstract 1
Many plaintiffs claim they required hospitalization, emergency treatment, surgery, specialist care, or long-term medical monitoring after developing complications associated with GLP-1 medications
Vomiting In more severe cases, nausea can progress to vomiting
This is a promising idea in the context of prevention and longevity medicinebut no specific microdosing trials have been conducted to prove it
